# Diagnostic Performance of Breast Cancer Screening Second Reading Process Assisted by AI

> **NCT05800132** · NA · RECRUITING · sponsor: **Therapixel** · enrollment: 5000 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** MammoScreen

## Key facts

- **NCT ID:** NCT05800132
- **Lead sponsor:** Therapixel
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2025-08
- **Final completion:** 2027-09
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05800132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05800132, "Diagnostic Performance of Breast Cancer Screening Second Reading Process Assisted by AI". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05800132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*